Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers

BACKGROUND: Circulating tumor DNA (ctDNA) has been becoming a novel convenient and noninvasive method for dynamically monitoring landscape of genomic information to guild personalized cancer treatment. In this study we comprehensively evaluated the additional value of plasma ctDNA to routine tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jianjiang, Yao, Weishen, Chen, Lingxiu, Zhu, Wenjun, Liu, Qiang, Geng, Geng, Fang, Jing, Zhao, Yang, Xiao, Li, Huang, Zhenhua, Zhao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063947/
https://www.ncbi.nlm.nih.gov/pubmed/37004022
http://dx.doi.org/10.1186/s12885-023-10674-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063947/
https://www.ncbi.nlm.nih.gov/pubmed/37004022
http://dx.doi.org/10.1186/s12885-023-10674-z

Ejemplares similares